Telemedicine in Drug Hypersensitivity
Department
Allergy and Immunology
Document Type
Article
Publication Title
Immunology and Allergy Clinics of North America
Abstract
This review focuses on the current applications of telemedicine for drug hypersensitivity reactions. Telemedicine holds promise as a tool to risk-stratify patients with drug hypersensitivity, for both evaluation of penicillin allergies and severe cutaneous adverse reactions. Although telemedicine may not fully replace in-person assessment owing to the need for testing, challenges, and in-person physical examination or skin biopsy, it may allow for risk stratification whereby some in-person visits may not be necessary. Electronic consults have also emerged along with telemedicine as a tool for drug allergy evaluations.
First Page
323
Last Page
333
DOI
10.1016/j.iac.2021.12.007
Volume
42
Issue
2
Publication Date
5-2022
PubMed ID
35469621
Recommended Citation
Wells, D., DeNiro, K. L., & Ramsey, A. (2022). Telemedicine in Drug Hypersensitivity. Immunology and Allergy Clinics of North America, 42 (2), 323-333. https://doi.org/10.1016/j.iac.2021.12.007